40.66
3.88%
1.52
시간 외 거래:
40.90
0.24
+0.59%
전일 마감가:
$39.14
열려 있는:
$38.66
하루 거래량:
1.01M
Relative Volume:
2.24
시가총액:
$2.63B
수익:
$87.56M
순이익/손실:
$-167.47M
주가수익비율:
-14.73
EPS:
-2.76
순현금흐름:
$-148.20M
1주 성능:
-3.49%
1개월 성능:
-7.70%
6개월 성능:
+30.03%
1년 성능:
+65.96%
Kymera Therapeutics Inc Stock (KYMR) Company Profile
명칭
Kymera Therapeutics Inc
전화
857-285-5314
주소
500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN
KYMR을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
KYMR
Kymera Therapeutics Inc
|
40.66 | 2.63B | 87.56M | -167.47M | -148.20M | -2.34 |
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Kymera Therapeutics Inc Stock (KYMR) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-12-10 | 개시 | BTIG Research | Buy |
2024-12-06 | 개시 | BMO Capital Markets | Market Perform |
2024-12-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2024-11-18 | 개시 | Stephens | Overweight |
2024-09-09 | 재개 | Leerink Partners | Outperform |
2024-08-26 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
2024-04-22 | 개시 | Oppenheimer | Outperform |
2024-02-15 | 개시 | Wolfe Research | Peer Perform |
2024-01-04 | 업그레이드 | JP Morgan | Neutral → Overweight |
2024-01-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
2023-12-19 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2023-06-30 | 개시 | Truist | Buy |
2023-05-05 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2022-12-06 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
2022-11-08 | 개시 | Raymond James | Mkt Perform |
2022-08-15 | 개시 | Jefferies | Buy |
2022-08-03 | 개시 | Goldman | Buy |
2022-07-20 | 개시 | SVB Leerink | Mkt Perform |
2022-04-28 | 개시 | Credit Suisse | Outperform |
2022-03-10 | 개시 | JP Morgan | Neutral |
2022-02-10 | 개시 | Wells Fargo | Overweight |
2021-09-30 | 개시 | B. Riley Securities | Neutral |
2021-09-30 | 개시 | Stifel | Buy |
2021-09-10 | 다운그레이드 | BofA Securities | Buy → Neutral |
2021-05-21 | 개시 | UBS | Buy |
2021-04-14 | 개시 | Berenberg | Buy |
2020-12-04 | 개시 | H.C. Wainwright | Buy |
2020-09-15 | 개시 | BofA Securities | Neutral |
2020-09-15 | 개시 | Cowen | Outperform |
2020-09-15 | 개시 | Guggenheim | Buy |
2020-09-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
Kymera Therapeutics Inc 주식(KYMR)의 최신 뉴스
HighTower Advisors LLC Takes $494,000 Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World
BMO Capital Initiates Coverage of Kymera Therapeutics (KYMR) with Market Perform Recommendation - MSN
BTIG Initiates Coverage of Kymera Therapeutics (KYMR) with Buy Recommendation - MSN
State Street Corp Has $81.79 Million Stock Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Shares Sold by Verition Fund Management LLC - Defense World
(KYMR) Investment Analysis - Stock Traders Daily
Kymera Therapeutics (NASDAQ:KYMR) Now Covered by BTIG Research - MarketBeat
Two Sigma Advisers LP Lowers Holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Wellington Management Group LLP Has $218.59 Million Stock Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Kymera Therapeutics (NASDAQ:KYMR) Research Coverage Started at BMO Capital Markets - Defense World
Kymera: Protein Degradation Could Drive Dupixent-Like Value (NASDAQ:KYMR) - Seeking Alpha
BMO Capital Markets Initiates Coverage on Kymera Therapeutics (NASDAQ:KYMR) - MarketBeat
Thrivent Financial for Lutherans Takes $313,000 Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World
The Manufacturers Life Insurance Company Has $6.07 Million Stock Holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World
BMO sets Kymera Therapeutics target at $55, rates Market Perform By Investing.com - Investing.com Canada
Kymera Therapeutics, Inc. (NASDAQ:KYMR) is Redmile Group LLC's 5th Largest Position - MarketBeat
(KYMR) Long Term Investment Analysis - Stock Traders Daily
Bamco Inc. NY Invests $1.18 Million in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Erste Asset Management GmbH Acquires New Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Kymera therapeutics director Pamela Esposito sells shares worth $122,500 By Investing.com - Investing.com Nigeria
Kymera therapeutics director Pamela Esposito sells shares worth $122,500 - Investing.com India
12,743 Shares in Kymera Therapeutics, Inc. (NASDAQ:KYMR) Purchased by HighVista Strategies LLC - MarketBeat
Cinctive Capital Management LP Acquires Shares of 56,801 Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Kymera Therapeutics shares rating upgraded on positive outlook By Investing.com - Investing.com Canada
Kymera Therapeutics (NASDAQ:KYMR) Upgraded by Wells Fargo & Company to Overweight Rating - Defense World
Wells Fargo Upgrades Kymera Therapeutics (KYMR) - MSN
Wells Fargo sees this biotech stock rallying 75% in its bull case - Head Topics
Fred Alger Management LLC Invests $859,000 in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Fmr LLC Boosts Position in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Intech Investment Management LLC Invests $650,000 in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Intech Investment Management LLC Makes New $650,000 Investment in Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Shares Bought by Eventide Asset Management LLC - MarketBeat
14,378 Shares in Kymera Therapeutics, Inc. (NASDAQ:KYMR) Bought by Natixis Advisors LLC - MarketBeat
Natixis Advisors LLC Purchases Shares of 14,378 Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World
Kymera Therapeutics announces proposed underwritten offering - MSN
Kymera Therapeutics to Participate in Upcoming December Investor Conferences - The Manila Times
Kymera Therapeutics to Present at Major Healthcare Investment Conferences in December | KYMR Stock News - StockTitan
Massachusetts Financial Services Co. MA Purchases 47,507 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
(KYMR) Trading Report - Stock Traders Daily
Jennison Associates LLC Purchases 368,394 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR) - MarketBeat
Stephens Begins Coverage on Kymera Therapeutics (NASDAQ:KYMR) - Defense World
Kymera Therapeutics (NASDAQ:KYMR) Coverage Initiated by Analysts at Stephens - MarketBeat
US Bancorp DE Sells 651 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR) - Defense World
Kymera Therapeutics (NASDAQ:KYMR) Shares Down 6.7%Here's What Happened - MarketBeat
Avoro Capital Advisors LLC Expands Stake in Kymera Therapeutics Inc - GuruFocus.com
Long Term Trading Analysis for (KYMR) - Stock Traders Daily
FMR LLC Bolsters Stake in Kymera Therapeutics Inc - GuruFocus.com
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Receives $51.21 Average Price Target from Analysts - Defense World
Kymera Therapeutics (NASDAQ:KYMR) Price Target Raised to $49.00 at Morgan Stanley - Defense World
Analysts Set Kymera Therapeutics, Inc. (NASDAQ:KYMR) Target Price at $51.21 - MarketBeat
Kymera Therapeutics Inc (KYMR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):